SELANK Peptide – User Manual & Dosage Protocol Guide

1

Product Overview

Selank is a synthetic heptapeptide analog of the naturally occurring tuftsin peptide, developed primarily for its anxiolytic, neuroprotective, and cognitive-enhancing properties.

Research Applications:

  • Reducing anxiety and stress-related responses
  • Supporting cognitive function, memory, and focus
  • Modulating immune and neuroimmune responses
  • Potential mood stabilization

Disclaimer: Selank is for research and experimental use only. It is not FDA-approved for medical use. Consult a qualified healthcare professional before use.

2

Forms Available

Product Form

Lyophilized Powder – Freeze-dried Selank for reconstitution

Nasal Spray Solution – Ready-to-use intranasal administration

Injection Solution – Subcutaneous (SC) or intramuscular (IM) solution after reconstitution

3

Mechanism of Action

Selank is believed to act via:

  • Modulation of GABAergic and serotonergic systems, promoting anxiolytic effects
  • Neuropeptide regulation, enhancing cognitive processes
  • Supporting immune system modulation and neuroprotection

Effects are primarily observed in research studies and experimental protocols.

4

Dosage Protocol (Investigational)

Administration

Subcutaneous (SC) Injection – Typical Dose: 250–500 µg | Frequency: 1–3× per day | Notes: Administer at consistent times for best results

Intranasal Spray – Typical Dose: 250–500 µg per dose | Frequency: 1–2× per day | Notes: Administer evenly between nostrils

Intramuscular (IM) Injection – Typical Dose: 250–500 µg | Frequency: 1–2× per day | Notes: Often used in research for systemic effect

Cycle Protocol (Investigational)

Initial Phase (5–7 days) – Dose: 250 µg 1–2× per day | Notes: Assess tolerance

Therapeutic Phase (2–4 weeks) – Dose: 250–500 µg 1–3× per day | Notes: Optimal cognitive and anxiolytic effects

Rest Period (1–2 weeks) – Dose: None | Notes: Allows system to reset before next cycle

Experimental cycles may be repeated 2–4 times per year depending on research goals.

5

Reconstitution Instructions (Lyophilized Powder)

Supplies Needed:

  • Sterile bacteriostatic water
  • Sterile syringe
  • Alcohol swabs

Steps:

  1. Clean vial top with alcohol swab.
  2. Add the desired volume of bacteriostatic water (e.g., 1 mg peptide + 1 mL water → 1 mg/mL solution).
  3. Swirl gently to dissolve; do not shake.
  4. Store refrigerated (2–8°C).
  5. Use within 2–4 weeks; discard if cloudy or discolored.
6

Administration Guidelines

Subcutaneous Injection (SC)
  1. Select a clean injection site (abdomen, thigh, or upper arm).
  2. Clean with alcohol swab.
  3. Insert needle at 45° angle.
  4. Inject slowly; apply gentle pressure afterward.
  5. Rotate injection sites to avoid tissue irritation.
Intramuscular Injection (IM)
  1. Select clean muscle site (deltoid, glute, thigh).
  2. Clean site with alcohol swab.
  3. Insert needle at 90° angle; inject slowly.
  4. Apply gentle pressure afterward.
Intranasal Administration
  1. Use the recommended dose (usually 250–500 µg) per nostril.
  2. Tilt head slightly back and spray evenly in both nostrils.
  3. Avoid immediate rinsing of nostrils for best absorption.
7

Storage Guidelines

Storage Information

Lyophilized Powder – Storage: Cool, dry place | Shelf Life: Up to 12 months

Reconstituted Solution – Storage: Refrigerate 2–8°C | Shelf Life: 2–4 weeks

Nasal Spray – Storage: Refrigerate or room temperature as per manufacturer | Shelf Life: 1–2 months

Discard solution if cloudy, discolored, or containing particulates.

8

Safety & Precautions

  • Not recommended for pregnant or breastfeeding women
  • Avoid if allergic to peptides
  • Mild side effects may include nasal irritation, mild headache, or injection site redness
  • Discontinue if severe adverse reactions occur
  • Keep out of reach of children

Human clinical data are limited; effects are investigational.

9

Quick Reference Cycle Chart (Investigational)

Weekly Cycle ScheduleWeek 1 – Dose: 250 µg SC/IM/Nasal 1× per day | Notes: Initial tolerance phase

Week 2–4 – Dose: 250–500 µg SC/IM/Nasal 1–3× per day | Notes: Therapeutic phase

Week 5+ – Dose: Rest 1–2 weeks | Notes: Reset before next cycle

10

Visual Guide

  • Diagrams of SC and IM injection sites (abdomen, thigh, arm, deltoid, glute)
  • Step-by-step nasal spray guide
  • Step-by-step reconstitution guide
  • Safety icons for handling, storage, and injections